Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Rho Kinase in Atherosclerosis
NCT00115817Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atorvastatin in atherosclerosis, sponsored by Brigham and Women's Hospital. Started Jun 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00115817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115817.